SK284689B6 - Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom - Google Patents

Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom Download PDF

Info

Publication number
SK284689B6
SK284689B6 SK1197-2000A SK11972000A SK284689B6 SK 284689 B6 SK284689 B6 SK 284689B6 SK 11972000 A SK11972000 A SK 11972000A SK 284689 B6 SK284689 B6 SK 284689B6
Authority
SK
Slovakia
Prior art keywords
benzopyrano
dihydro
trimethyl
quinoline
methoxy
Prior art date
Application number
SK1197-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK11972000A3 (sk
Inventor
Michael J. Coughlan
Steven W. Elmore
Michael E. Kort
Philip R. Kym
Jimmie L. Moore
John K. Pratt
Alan X. Wang
James P. Edwards
Todd K. Jones
Original Assignee
Abbott Laboratories
Ligand Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories, Ligand Pharmaceuticals, Inc. filed Critical Abbott Laboratories
Publication of SK11972000A3 publication Critical patent/SK11972000A3/sk
Publication of SK284689B6 publication Critical patent/SK284689B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SK1197-2000A 1998-02-13 1999-02-12 Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom SK284689B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10
PCT/US1999/003127 WO1999041256A1 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Publications (2)

Publication Number Publication Date
SK11972000A3 SK11972000A3 (sk) 2001-08-06
SK284689B6 true SK284689B6 (sk) 2005-09-08

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1197-2000A SK284689B6 (sk) 1998-02-13 1999-02-12 Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom

Country Status (21)

Country Link
EP (1) EP1053239B1 (ja)
JP (1) JP2002503665A (ja)
KR (1) KR20010040935A (ja)
CN (1) CN1119348C (ja)
AT (1) ATE230749T1 (ja)
AU (1) AU766441B2 (ja)
BG (1) BG64317B1 (ja)
BR (1) BR9907788A (ja)
CA (1) CA2320943A1 (ja)
DE (1) DE69904804T2 (ja)
DK (1) DK1053239T3 (ja)
ES (1) ES2192035T3 (ja)
HK (1) HK1033308A1 (ja)
HU (1) HUP0100460A3 (ja)
IL (1) IL137508A0 (ja)
NO (1) NO20004053L (ja)
NZ (1) NZ506013A (ja)
PL (1) PL193323B1 (ja)
SK (1) SK284689B6 (ja)
TR (1) TR200003094T2 (ja)
WO (1) WO1999041256A1 (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
CO5180649A1 (es) * 1999-09-01 2002-07-30 Abbott Lab Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6593480B2 (en) * 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
ES2246292T3 (es) 2000-10-30 2006-02-16 Pfizer Products Inc. Moduladores de receptor glucocorticoide.
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
DE60309829T2 (de) 2002-01-14 2007-09-13 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Glucocorticoidmimetika, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische formulierungen und ihre verwendungen
MXPA04009329A (es) 2002-03-26 2005-01-25 Boehringer Ingelheim Pharma Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y usos de los mismos.
US7268152B2 (en) 2002-03-26 2007-09-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE60335869D1 (de) 2002-04-11 2011-03-10 Merck Sharp & Dohme 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003259747A1 (en) 2002-08-21 2004-03-11 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
WO2004033459A1 (en) * 2002-10-11 2004-04-22 Ligand Pharmaceuticals Incorporated 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO[3,4-f]QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
JP2006508076A (ja) * 2002-10-11 2006-03-09 リガンド・ファーマシューティカルズ・インコーポレイテッド 選択的プロゲステロン受容体モジュレーター化合物としての5−シクロアルケニル5H−クロメノ[3,4−f]キノリン誘導体
JP4373926B2 (ja) 2003-01-03 2009-11-25 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 1−プロパノール及び1−プロピルアミン誘導体ならびにグルココルチコイドリガンドとしての使用
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7507843B2 (en) 2003-10-16 2009-03-24 Boehringer Ingelheim Pharmaceuticals, Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US7741361B2 (en) 2004-12-27 2010-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US8017775B2 (en) * 2005-09-14 2011-09-13 Santen Pharmaceutical Co., Ltd. 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
AR077101A1 (es) 2009-06-16 2011-08-03 Schering Corp Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos
EP2459524A2 (en) 2009-07-31 2012-06-06 Cadila Healthcare Limited Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ176197A3 (cs) * 1994-12-22 1998-09-16 Ligand Pharmaceuticals Incorporated Modulátory steroidových receptorů a způsoby jejich přípravy a použití

Also Published As

Publication number Publication date
DK1053239T3 (da) 2003-04-22
CN1296486A (zh) 2001-05-23
NO20004053D0 (no) 2000-08-11
NZ506013A (en) 2003-03-28
CN1119348C (zh) 2003-08-27
PL193323B1 (pl) 2007-02-28
HUP0100460A3 (en) 2003-03-28
AU2677399A (en) 1999-08-30
HUP0100460A2 (hu) 2001-09-28
WO1999041256A1 (en) 1999-08-19
EP1053239A1 (en) 2000-11-22
TR200003094T2 (tr) 2001-01-22
IL137508A0 (en) 2001-07-24
BG64317B1 (bg) 2004-09-30
KR20010040935A (ko) 2001-05-15
ATE230749T1 (de) 2003-01-15
AU766441B2 (en) 2003-10-16
DE69904804D1 (de) 2003-02-13
DE69904804T2 (de) 2003-11-06
BR9907788A (pt) 2001-10-30
BG104719A (en) 2001-05-31
NO20004053L (no) 2000-09-11
ES2192035T3 (es) 2003-09-16
JP2002503665A (ja) 2002-02-05
HK1033308A1 (en) 2001-08-24
PL343018A1 (en) 2001-07-30
EP1053239B1 (en) 2003-01-08
SK11972000A3 (sk) 2001-08-06
CA2320943A1 (en) 1999-09-19

Similar Documents

Publication Publication Date Title
SK284689B6 (sk) Benzopyrano[3,4-f]chinolínová zlúčenina a liečivo s jej obsahom
US6951942B2 (en) Glucocorticoid-selective anti-inflammatory agents
DE60305446T4 (de) Desazapurine und deren verwendung
EP2041142B1 (de) Spirocyclische azaindol-derivate
EP1851214B1 (en) Isoxazoline derivative and novel process for its preparation
CN111285850A (zh) 一类异吲哚啉类化合物、其制备方法、药物组合物及其应用
TW200808808A (en) Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
CA3046212A1 (en) Heterocyclic inhibitors of mct4
CZ424798A3 (cs) Spiropiperidinové deriváty, způsob výroby a farmaceutický prostředek
EA027113B1 (ru) Регуляторы пути комплемента и их применение
CA3172478A1 (en) Bcl-2 inhibitor
US20230128062A1 (en) Azabicyclic substituted oxaspiro derivative, preparation method therefor and medical use thereof
EP3337800A1 (de) Verfahren zur herstellung von (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamid und dessen aufreinigung für die verwendung als pharmazeutischer wirkstoff
JP2023513373A (ja) P2x3修飾薬
JP2002508359A (ja) 複素環式細胞毒性剤
KR20000070756A (ko) 동맥경화증 및 지단백질과잉혈증 치료에 사용되는 2-아미노 치환된 피리딘
US11459353B2 (en) Steroids and methods of manufacture
DE10250687A1 (de) 7H-Dibenzo(b,g)(1,5)dioxocin-5-on-Derivate und ihre Verwendung
CZ20002893A3 (cs) Glukokortikoidně selektivní protizánětlivé látky
CA2362272A1 (en) Spirocyclic ketones and their use as tachykinin antagonists
MXPA00007944A (en) Glucocorticoid-selective anti-inflammatory agents
RU2800296C1 (ru) Оксаспиро-производное, замещенное по азабициклическому кольцу, способ его получения и его медицинское применение
CN113831346B (zh) 多靶点抗肿瘤小分子及其衍生物、制法、药物组合物和应用
NO309506B1 (no) Anxiolytisk middel, bisyklolaktamforbindelse og anvendelse av nye og kjente bisyklolaktamforbindelser
WO2013149996A9 (en) Substituted tricyclic compounds with activity towards ep1 receptors